Deletion of Cop1 in cancer cells led to upregulation of C/ebpδ protein stability, which suppresses expression of chemokines involved in macrophage infiltration, thus demonstrating that Cop1 can serve as a target for increasing immunotherapy effectiveness by modulating macrophage infiltration in TNBC [80]. This evidence concerns the gene COP1 and cancer.